°µÍø³Ô¹Ï

$98.3 Million
Oncorus, Inc.
Initial Public Offering
Active Bookrunner
$57.0 Million
TELA Bio, Inc.
Initial Public Offering
Active Bookrunner
$92.0 Million
Oyster Point Pharma, Inc.
Initial Public Offering
Active Bookrunner
$201.3 Million
IGM Biosciences, Inc.
Initial Public Offering
Active Bookrunner
$60.7 Million
Bicycle Therapeutics Limited
Initial Public Offering
Active Bookrunner
$82.5 Million
Milestone Pharmaceuticals Inc.
Initial Public Offering
Active Bookrunner
$165.6 Million
Pliant Therapeutics, Inc.
Initial Public Offering
Active Bookrunner
$120.0 Million
Arvinas
Initial Public Offering
Active Bookrunner
$117.3 Million
Crinetics Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$138.0 Million
OptiNose AS
Initial Public Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 °µÍø³Ô¹Ï. Since 1895. All rights reserved.